Search Results - "Tapete, Gherardo"
-
1
From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
Published in World journal of gastroenterology : WJG (07-09-2018)“…Fecal calprotectin (FC) has emerged as one of the most useful tools for clinical management of inflammatory bowel diseases (IBD). Many different methods of…”
Get full text
Journal Article -
2
Thrombosis in inflammatory bowel diseases: what's the link?
Published in Thrombosis journal (02-04-2015)“…Inflammatory bowel disease affects more than 2 million people in Europe, with almost 20% of patients being diagnosed in pediatric age. Patients with…”
Get full text
Journal Article -
3
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study
Published in Clinical and translational gastroenterology (01-05-2020)“…Biological therapies are widely used for the treatment of ulcerative colitis. However, only a low proportion of patients achieve clinical remission and even…”
Get full text
Journal Article -
4
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis
Published in Digestive diseases and sciences (01-08-2020)“…Background Ulcerative colitis is a chronic relapsing disease usually treated with mesalamine. The need of steroid therapy at diagnosis is generally considered…”
Get full text
Journal Article -
5
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Published in United European gastroenterology journal (01-11-2019)“…Background Data from trials of vedolizumab for inflammatory bowel disease and from real-world studies suggest an exposure-response relationship, such that…”
Get full text
Journal Article -
6
Suspected stenosis in Caroli syndrome: when cholangioscopy can be the game changer
Published in VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy (01-06-2024)“…[Display omitted]…”
Get full text
Journal Article -
7
A Rare Case of Esophageal Tubular Duplication
Published in Journal of gastrointestinal and liver diseases : JGLD (31-03-2023)Get full text
Journal Article -
8
Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment
Published in European journal of gastroenterology & hepatology (01-09-2020)“…Fecal calprotectin has been widely studied in inflammatory bowel disease (IBD) under clinical and therapeutic settings. It showed a good correlation with…”
Get full text
Journal Article -
9
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry
Published in Inflammatory bowel diseases (05-01-2022)“…Abstract Background Few data are currently available about SB5 in inflammatory bowel diseases (IBD). The aim of this study was to assess the effectiveness and…”
Get full text
Journal Article -
10
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients
Published in British journal of clinical pharmacology (01-07-2020)“…Aims Vedolizumab (VDZ) prevents migration of activated leucocytes into inflamed mucosa. This study aimed to assess the patterns of serum cytokines in…”
Get full text
Journal Article -
11
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab
Published in Alimentary pharmacology & therapeutics (01-07-2020)“…Summary Background Oncostatin M is upregulated in Crohn's disease inflamed intestinal mucosa, and has been suggested as a promising biomarker to predict…”
Get full text
Journal Article -
12
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
Published in Inflammatory bowel diseases (01-10-2020)“…Abstract Background Anti-tumor necrosis factor drugs (anti-TNFs) are widely used for the treatment of ulcerative colitis (UC). However, many patients…”
Get full text
Journal Article -
13
Tu1241 SERUM ONCOSTATIN M PREDICTS MUCOSAL HEALING IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2020)Get full text
Journal Article -
14
-
15
Overlap of GERD and gastrointestinal functional disorders
Published in Minerva gastroenterologica e dietologica (01-09-2017)“…The functional gastrointestinal disorders (FGIDs) are common conditions with an overall prevalence burden estimated at approximately one-third of the…”
Get more information
Journal Article -
16
Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
Published in Journal of hepatocellular carcinoma (01-01-2017)“…According to the current European Association for the Study of Liver guidelines, transarterial chemoembolization (TACE) is the recommended first-line therapy…”
Get full text
Journal Article -
17
Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life study
Published in Future oncology (London, England) (01-12-2018)“…This multicenter field-practice study evaluates outcomes of long-term sorafenib in hepatocellular carcinoma (HCC) patients. Consecutive HCC patients on…”
Get full text
Journal Article -
18
Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study
Published in United European gastroenterology journal (01-02-2021)“…Background Few data exist regarding the long‐term effectiveness of golimumab in ulcerative colitis. No data have been reported on real‐world continuous…”
Get full text
Journal Article -
19
-
20